Cancer is one of the most prevalent medical disorders throughout the world. It is estimated that the incidence of cancer will increase by 50% by the year 2020, with 16 million new cases in the year 2020. At the same time, earlier diagnoses and improvement in cancer therapies have allowed patients to survive with a better quality of life. Depression is among the most common and prevalent psychiatric disorders in cancer patients. Data accumulated over the last 20 years have investigated the epidemiology and pathogenesis of depressive disorders in patients with cancer, how depression influences patients’ quality of life and the lives of their families, and the efficacy of psychiatric and psychosocial interventions in depressed patients with cancer. The chapter examines the prevalence, pathogenesis, diagnosis, and treatment of depressive disorders in cancer patients.
Depressive Disorders in Oncology
GRASSI, Luigi;
2008
Abstract
Cancer is one of the most prevalent medical disorders throughout the world. It is estimated that the incidence of cancer will increase by 50% by the year 2020, with 16 million new cases in the year 2020. At the same time, earlier diagnoses and improvement in cancer therapies have allowed patients to survive with a better quality of life. Depression is among the most common and prevalent psychiatric disorders in cancer patients. Data accumulated over the last 20 years have investigated the epidemiology and pathogenesis of depressive disorders in patients with cancer, how depression influences patients’ quality of life and the lives of their families, and the efficacy of psychiatric and psychosocial interventions in depressed patients with cancer. The chapter examines the prevalence, pathogenesis, diagnosis, and treatment of depressive disorders in cancer patients.I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
